In some countries, this medicine may only be approved for veterinary use.
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L02AE01
CAS registry number (Chemical Abstracts Service)
0057982-77-1
Chemical Formula
C60-H86-N16-O13
Molecular Weight
1239
Therapeutic Categories
Antineoplastic agent
Gonadotropin releasing hormone (GnRH) agonist
Chemical Name
Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-
Foreign Names
- Buserelinum (Latin)
- Buserelin (German)
- Buséréline (French)
- Buserelina (Spanish)
Generic Names
- Buserelin (OS: BAN)
- Buserelina (OS: DCIT)
- Buséréline (OS: DCF)
- Hoe 766 (IS)
- S 746766 (IS)
- Buserelin (PH: BP 2010, Ph. Eur. 6)
- Buséréline (PH: Ph. Eur. 6)
- Buserelinum (PH: Ph. Eur. 6)
- Buserelin Acetate (OS: JAN, USAN, BANM)
Brand Names
- Receptal (veterinary use)
Hoechst Roussel Vet, Portugal; Hoechst Vet, Ireland; Intervet, United Kingdom - Suprefact
Aventis, Singapore - Bigonist
Sanofi-Aventis, France - Buserecur
Fuji Yakuhin, Japan - Buserelin aniMedica (veterinary use)
Animedica, Austria; Animedica, Germany; Animedica, Poland - Buserol (veterinary use)
Gräub, Switzerland - Busol (veterinary use)
Laboratoires Biové, France - Fuset
Mylan Pharmaceutical, Japan - Itorelin
ILSIto Life Sciences, Japan - Metrelef
Ferring, Germany - Profact
Sanofi-Aventis, Germany - Receptal (veterinary use)
Intervet, Austria; Intervet, Belgium; Intervet, Germany; Intervet, Finland; Intervet, Italy; Intervet, Netherlands; Intervet, Norway; Intervet, Sweden; Intervet, South Africa; Intervet / Schering-Plough Animal Health, New Zealand; Intervet/Schering-Plough Animal Health, Australia; Veterinaria, Switzerland - Réceptal (veterinary use)
Intervet, France - Suprecur
Sanofi Aventis, Japan; Sanofi-Aventis, Austria; Sanofi-Aventis, Denmark; Sanofi-Aventis, Finland; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Ireland; Sanofi-Aventis, Norway; Sanofi-Aventis, Sweden; Sanofi-Aventis, Turkey - Suprefact Nasal
Sanofi-Aventis S.A., Spain - Suprefact
Aventis, Israel; Aventis, Iceland; Aventis, Luxembourg; Aventis, Serbia; Aventis, Slovakia; Aventis, South Africa; Dr. Fisher, Netherlands; Euro, Netherlands; Medcor, Netherlands; Sanofi-Aventis, Argentina; Sanofi-Aventis, Austria; Sanofi-Aventis, Belgium; Sanofi-Aventis, Bahrain; Sanofi-Aventis, Canada; Sanofi-Aventis, Denmark; Sanofi-Aventis, Egypt; Sanofi-Aventis, Finland; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Greece; Sanofi-Aventis, Hungary; Sanofi-Aventis, Ireland; Sanofi-Aventis, Iraq; Sanofi-Aventis, Iran; Sanofi-Aventis, Italy; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Malta; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Netherlands; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Oman; Sanofi-Aventis, Qatar; Sanofi-Aventis, Saudi Arabia; Sanofi-Aventis, Sweden; Sanofi-Aventis, Singapore; Sanofi-Aventis, Syria; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Yemen; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Aventis S.A., Spain; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Jordan - Suprefact Depot
Aventis, Brazil; Sanofi-Aventis, Austria; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Hungary; Sanofi-Aventis, Israel; Sanofi-Aventis, Norway; Sanofi-Aventis, Sweden; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Aventis S.A., Spain - Supremon
Sanofi-Aventis, Taiwan
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Buserelin is a potent LHRH agonist. After a transient increase, continuous administration results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis. Buserelin Acetate
ReplyDelete